Correlation Between Connect Biopharma and Rhythm Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Rhythm Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Rhythm Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Rhythm Pharmaceuticals, you can compare the effects of market volatilities on Connect Biopharma and Rhythm Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Rhythm Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Rhythm Pharmaceuticals.
Diversification Opportunities for Connect Biopharma and Rhythm Pharmaceuticals
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Connect and Rhythm is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Rhythm Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rhythm Pharmaceuticals and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Rhythm Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rhythm Pharmaceuticals has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Rhythm Pharmaceuticals go up and down completely randomly.
Pair Corralation between Connect Biopharma and Rhythm Pharmaceuticals
Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the Rhythm Pharmaceuticals. In addition to that, Connect Biopharma is 1.09 times more volatile than Rhythm Pharmaceuticals. It trades about -0.23 of its total potential returns per unit of risk. Rhythm Pharmaceuticals is currently generating about 0.23 per unit of volatility. If you would invest 4,943 in Rhythm Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 1,049 from holding Rhythm Pharmaceuticals or generate 21.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Connect Biopharma Holdings vs. Rhythm Pharmaceuticals
Performance |
| Timeline |
| Connect Biopharma |
| Rhythm Pharmaceuticals |
Connect Biopharma and Rhythm Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Connect Biopharma and Rhythm Pharmaceuticals
The main advantage of trading using opposite Connect Biopharma and Rhythm Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Rhythm Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rhythm Pharmaceuticals will offset losses from the drop in Rhythm Pharmaceuticals' long position.| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
| Rhythm Pharmaceuticals vs. Revolution Medicines | Rhythm Pharmaceuticals vs. Akero Therapeutics | Rhythm Pharmaceuticals vs. Avidity Biosciences | Rhythm Pharmaceuticals vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |